BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

388 related articles for article (PubMed ID: 15725561)

  • 1. Enhanced paclitaxel bioavailability after oral coadministration of paclitaxel prodrug with naringin to rats.
    Choi JS; Shin SC
    Int J Pharm; 2005 Mar; 292(1-2):149-56. PubMed ID: 15725561
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced paclitaxel bioavailability after oral administration of paclitaxel or prodrug to rats pretreated with quercetin.
    Choi JS; Jo BW; Kim YC
    Eur J Pharm Biopharm; 2004 Mar; 57(2):313-8. PubMed ID: 15018990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Enhanced paclitaxel bioavailability after oral administration of pegylated paclitaxel prodrug for oral delivery in rats.
    Choi JS; Jo BW
    Int J Pharm; 2004 Aug; 280(1-2):221-7. PubMed ID: 15265561
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered pharmacokinetics of paclitaxel by the concomitant use of morin in rats.
    Choi BC; Choi JS; Han HK
    Int J Pharm; 2006 Oct; 323(1-2):81-5. PubMed ID: 16806758
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The effect of verapamil on the pharmacokinetics of paclitaxel in rats.
    Choi JS; Li X
    Eur J Pharm Sci; 2005 Jan; 24(1):95-100. PubMed ID: 15626582
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of water-soluble prodrugs of the HIV-1 protease inhibitor KNI-727: importance of the conversion time for higher gastrointestinal absorption of prodrugs based on spontaneous chemical cleavage.
    Sohma Y; Hayashi Y; Ito T; Matsumoto H; Kimura T; Kiso Y
    J Med Chem; 2003 Sep; 46(19):4124-35. PubMed ID: 12954064
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded nanosponges.
    Torne SJ; Ansari KA; Vavia PR; Trotta F; Cavalli R
    Drug Deliv; 2010 Aug; 17(6):419-25. PubMed ID: 20429848
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of baicalein, an antioxidant, on the bioavailability of doxorubicin in rats: possible role of P-glycoprotein inhibition by baicalein.
    Shin SC; Li C; Choi JS
    Pharmazie; 2009 Sep; 64(9):579-83. PubMed ID: 19827298
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced tamoxifen bioavailability after oral administration of tamoxifen in rats pretreated with naringin.
    Choi JS; Kang KW
    Arch Pharm Res; 2008 Dec; 31(12):1631-6. PubMed ID: 19099234
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Enhanced bioavailability of paclitaxel after oral coadministration with flavone in rats.
    Choi JS; Choi HK; Shin SC
    Int J Pharm; 2004 May; 275(1-2):165-70. PubMed ID: 15081147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of silymarin and formulation on the oral bioavailability of paclitaxel in rats.
    Park JH; Park JH; Hur HJ; Woo JS; Lee HJ
    Eur J Pharm Sci; 2012 Feb; 45(3):296-301. PubMed ID: 22172604
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced bioavailability of tamoxifen after oral administration of tamoxifen with quercetin in rats.
    Shin SC; Choi JS; Li X
    Int J Pharm; 2006 Apr; 313(1-2):144-9. PubMed ID: 16516418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Enhanced bioavailability of etoposide after oral or intravenous administration of etoposide with kaempferol in rats.
    Li C; Li X; Choi JS
    Arch Pharm Res; 2009 Jan; 32(1):133-8. PubMed ID: 19183886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bifunctional peptidomimetic prodrugs of didanosine for improved intestinal permeability and enhanced acidic stability: synthesis, transepithelial transport, chemical stability and pharmacokinetics.
    Yan Z; Sun J; Chang Y; Liu Y; Fu Q; Xu Y; Sun Y; Pu X; Zhang Y; Jing Y; Yin S; Zhu M; Wang Y; He Z
    Mol Pharm; 2011 Apr; 8(2):319-29. PubMed ID: 21280612
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lymphatic transport of Methylnortestosterone undecanoate (MU) and the bioavailability of methylnortestosterone are highly sensitive to the mass of coadministered lipid after oral administration of MU.
    White KL; Nguyen G; Charman WN; Edwards GA; Faassen WA; Porter CJ
    J Pharmacol Exp Ther; 2009 Nov; 331(2):700-9. PubMed ID: 19696095
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of lovastatin on the pharmacokinetics of verapamil and its active metabolite, norverapamil in rats: possible role of P-glycoprotein inhibition by lovastatin.
    Hong SP; Chang KS; Koh YY; Choi DH; Choi JS
    Arch Pharm Res; 2009 Oct; 32(10):1447-52. PubMed ID: 19898809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The ethanol metabolite acetaldehyde increases paracellular drug permeability in vitro and oral bioavailability in vivo.
    Fisher SJ; Swaan PW; Eddington ND
    J Pharmacol Exp Ther; 2010 Jan; 332(1):326-33. PubMed ID: 19820208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of silibinin, inhibitor of CYP3A4 and P-glycoprotein in vitro, on the pharmacokinetics of paclitaxel after oral and intravenous administration in rats.
    Lee CK; Choi JS
    Pharmacology; 2010; 85(6):350-6. PubMed ID: 20523105
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced bioavailability of verapamil after oral administration with hesperidin in rats.
    Piao YJ; Choi JS
    Arch Pharm Res; 2008 Apr; 31(4):518-22. PubMed ID: 18449511
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The influence of enaminones on the transport and oral bioavailability of P-glycoprotein substrate therapeutic agents.
    Salama NN; Scott KR; Eddington ND
    Int J Pharm; 2004 Apr; 273(1-2):135-47. PubMed ID: 15010138
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.